1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Gain Therapeutics, Inc.

Gain Therapeutics, Inc.

GANX
Gain Therapeutics, Inc.US flagNASDAQ Global Market
1.84
USD
+0.21
- -
78.48MMarket Cap

Income Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
1
2
4
14
18
22
20
19
+ Selling, General & Admin
- -
1
1
7
10
11
10
8
+ Research & Development
1
2
2
7
8
12
11
10
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-1
-2
-3
-14
-18
-22
-20
-19
- Non-Operating (Income) Loss
- -
- -
- -
- -
- -
- -
- -
1
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
- -
1
Pretax Income
-1
-2
-4
-14
-17
-22
-20
-19
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
1
1
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-1
-2
-4
-14
-18
-22
-20
-20
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-1
-2
-4
-14
-18
-22
-20
-20
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-2
-4
-14
-18
-22
-20
-20
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-1
-2
-4
-14
-18
-22
-20
-20
EBIT
-1
-2
-3
-14
-18
-22
-20
-19
EBITDA
-1
-2
-3
-14
-18
-22
-20
-19
EBITDA Margin (%)
-4,986.06
-5,078.66
-12,014.32
-8,370.42
-12,642.3
-40,176.79
- -
- -
EBITA
-1
-2
-3
-14
-18
-22
-20
-19
Gross Margin (%)
100
100
100
100
100
100
- -
- -
Operating Margin (%)
-4,989.66
-5,084.89
-12,047.54
-8,379.8
-12,688.1
-40,328.26
- -
- -
Profit Margin (%)
-5,364.36
-5,310.88
-12,387.67
-8,418.86
-12,555.13
-40,354.33
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
6
6
3
10
12
13
23
33
Basic EPS, GAAP
-0.19
-0.37
-1.33
-1.37
-1.48
-1.71
-0.89
-0.61
Basic EPS from Cont Ops
-0.19
-0.37
-1.33
-1.37
-1.48
-1.71
-0.89
-0.61
Diluted Weighted Avg Shares
6
6
3
10
12
13
23
33
Diluted EPS, GAAP
-0.19
-0.37
-1.33
-1.37
-1.48
-1.71
-0.89
-0.61
Diluted EPS from Cont Ops
-0.19
-0.37
-1.33
-1.37
-1.48
-1.71
-0.89
-0.61

Balance Sheet (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
- -
- -
9
38
21
18
12
22
+ Cash, Cash Equivalents & STI
- -
- -
7
37
20
17
10
21
+ Cash & Cash Equivalents
- -
- -
7
37
7
12
10
21
+ ST Investments
- -
- -
- -
- -
13
5
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
1
1
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
1
1
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
1
1
1
1
- -
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
1
1
3
1
1
1
+ Property, Plant & Equip, Net
- -
- -
1
1
1
1
- -
- -
+ Property, Plant & Equip
- -
- -
1
1
1
1
- -
1
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
2
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
2
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
- -
1
10
39
24
19
12
23
+ Payables & Accruals
- -
- -
2
2
4
3
3
3
+ Accounts Payable
- -
- -
1
1
2
1
1
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
1
1
2
2
2
2
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
- -
- -
1
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
1
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
- -
1
2
3
4
5
4
3
+ LT Debt
- -
- -
1
1
1
1
- -
1
+ LT Borrowings
- -
- -
1
1
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
1
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
- -
1
2
1
1
1
1
Total Liabilities
- -
1
3
4
5
6
5
4
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
3
13
56
57
73
89
119
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
3
13
56
57
73
89
119
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
- -
-3
-7
-21
-39
-61
-81
-101
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
1
Equity Before Minority Interest
- -
- -
6
35
19
13
7
19
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
6
35
19
13
7
19
Total Liabilities & Equity
- -
1
10
39
24
19
12
23
Shares Outstanding
- -
11
11
12
12
16
27
42
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
1
1
1
- -
- -
- -
Net Debt
- -
- -
-7
-36
-7
-11
-10
-20
Net Debt to Equity
- -
67.43
-108.91
-103.93
-35.53
-89.26
-135.53
-110.08
Tangible Common Equity Ratio
- -
-68.15
64.57
89.25
78.15
67.25
60.1
81.27
Current Ratio
- -
0.49
4.25
14.78
5.11
3.59
2.97
6.63
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-1
-2
-4
-14
-18
-22
-20
-20
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
- -
- -
2
1
3
3
3
+ Stock-Based Compensation
- -
- -
- -
1
2
3
2
2
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
1
- -
- -
- -
1
+ Chg in Non-Cash Work Cap
- -
- -
- -
- -
2
- -
-1
-1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
-1
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
- -
- -
- -
-1
1
-1
- -
- -
+ Inc (Dec) in Other
- -
- -
- -
1
1
1
-1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-1
-2
-3
-12
-15
-19
-19
-18
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
43
- -
13
13
25
+ Increase in Capital Stock
- -
- -
- -
43
- -
13
13
25
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
-15
10
5
- -
+ Dec in LT Investment
- -
- -
- -
- -
3
12
5
- -
+ Inc in LT Investment
- -
- -
- -
- -
-18
-2
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
-15
10
5
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
1
- -
1
- -
- -
- -
- -
- -
+ Cash From Debt
1
- -
1
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
2
10
-1
- -
- -
- -
3
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
1
2
10
42
- -
13
13
28
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
-1
- -
Net Changes in Cash
- -
- -
7
29
-30
4
-1
10
EBITDA
-1
-2
-3
-14
-18
-22
-20
-19
EBITDA Margin (%)
-4,986.06
-5,078.66
-12,014.32
-8,370.42
-12,642.3
-40,176.79
- -
- -
Free Cash Flow
-1
-2
-3
-12
-15
-19
-19
-18
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-2
-3
-12
-15
-19
-19
-19
Free Cash Flow per Basic Share
-0.13
-0.32
-1.22
-1.23
-1.25
-1.45
-0.83
-0.56
Price/Free Cash Flow
- -
- -
- -
-4.5
-2.55
-2.26
-2.62
-5.75
Cash Flow to Net Income
0.67
0.85
0.91
0.89
0.84
0.85
0.92
0.92
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -